Pinnacle Associates’s ResMed RMD Stock Holding History

Pinnacle Associates’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.56M	Sell	20,605 -69	-0.3%	-$15.1K	0.05%	282
2026 Q2	$4.03M	Sell	20,674 -8,110	-28%	-$1.68M	0.04%	308
2026 Q1	$6.46M	Sell	28,784 -701	-2%	-$175K	0.08%	224
2025 Q4	$7.1M	Sell	29,485 -222	-0.7%	-$56.8K	0.09%	214
2025 Q3	$8.13M	Sell	29,707 -56	-0.2%	-$15.3K	0.11%	189
2025 Q2	$7.68M	Sell	29,763 -3,354	-10%	-$800K	0.11%	185
2025 Q1	$7.41M	Sell	33,117 -2,336	-7%	-$545K	0.11%	190
2024 Q4	$8.11M	Buy	+35,453	New	+$8.54M	0.11%	183
2024 Q3	–	Sell	-36,716	Closed	-$7.03M	–	837
2024 Q2	$7.03M	Sell	36,716 -501	-1%	-$102K	0.11%	196
2024 Q1	$7.37M	Buy	+37,217	New	+$6.82M	0.12%	194

Other funds holding RMD

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.34B AUM 13.98% 1-Year Est. Return

Tandem Investment Advisors Charleston, South Carolina $1.39B AUM 7.74% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

Pinnacle Associates's RMD Position: Q3 2026 in Review

Pinnacle Associates reduced its ResMed (RMD) stake by 0.33% in Q3 2026, selling an estimated $15.1K and leaving 20,605 shares worth $4.56M. The position accounts for 0.05% of the portfolio, ranked #282.

Pinnacle Associates first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $8.13M in Q3 2025. 417 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

Pinnacle Associates held 20,605 shares of ResMed worth $4.56M as of Q3 2026.
Pinnacle Associates sold 69 ResMed shares in Q3 2026, an estimated $15.1K.
ResMed made up 0.05% of Pinnacle Associates's portfolio in Q3 2026, its #282 holding.
Pinnacle Associates first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
Pinnacle Associates's ResMed position peaked at $8.13M in Q3 2025.
417 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Pinnacle Associates's 13F filing for Q3 2026, filed 20 Oct 2026.